Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
Rossman
Joanne
J
Comprehensive Cancer Center, Division of Hematology-Oncology, University of Alabama at Birmingham, 1802 Sixth Avenue South, NPCC 2540, Birmingham, AL 35294-3300, United States.
Reddy
Vishnu
V
Cantor
Alan
A
Miley
Debi
D
Robert
Francisco
F